Key points from article :
Johnson & Johnson’s surgical robotic platform Ottava offers unrivalled flexibility and control.
Designed with six arms, it has a zero-footprint design to enable patient access and improve workflow.
J&J’s new platform is called Ottava which mean 'an octave higher' in Italian.
“That (an octave higher) is what we mean to enable in medical intervention,” said Dr. Moll, J&J.
Verification and validation processes for Ottava will begin in 2021.
Followed by enrollment in clinical trials for the device in 2022.
“We view Ottava as the surgeon’s instrument for orchestrating a new level and elevating the surgical experience” - Dr. Moll
